274 related articles for article (PubMed ID: 15525577)
1. The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17beta-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16alpha-hydroxyestradiol, and 4-hydroxyestrone.
Turan VK; Sanchez RI; Li JJ; Li SA; Reuhl KR; Thomas PE; Conney AH; Gallo MA; Kauffman FC; Mesia-Vela S
J Endocrinol; 2004 Oct; 183(1):91-9. PubMed ID: 15525577
[TBL] [Abstract][Full Text] [Related]
2. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D
Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
[TBL] [Abstract][Full Text] [Related]
3. Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: studies using Syrian hamster embryo cells treated with 17beta-estradiol and eight of its metabolites.
Tsutsui T; Tamura Y; Yagi E; Barrett JC
Int J Cancer; 2000 Apr; 86(1):8-14. PubMed ID: 10728588
[TBL] [Abstract][Full Text] [Related]
4. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
Ashburn SP; Han X; Liehr JG
Mol Pharmacol; 1993 Apr; 43(4):534-41. PubMed ID: 8386306
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.
Li KM; Todorovic R; Devanesan P; Higginbotham S; Köfeler H; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
Carcinogenesis; 2004 Feb; 25(2):289-97. PubMed ID: 14578156
[TBL] [Abstract][Full Text] [Related]
6. Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma.
Shull JD; Spady TJ; Snyder MC; Johansson SL; Pennington KL
Carcinogenesis; 1997 Aug; 18(8):1595-601. PubMed ID: 9276635
[TBL] [Abstract][Full Text] [Related]
7. Effect of catechol estrogens on rat mammary tumors.
Abul-Hajj YJ
Cancer Res; 1979 Dec; 39(12):4882-6. PubMed ID: 115583
[TBL] [Abstract][Full Text] [Related]
8. Tissue-selective effects of continuous release of 2-hydroxyestrone and 16alpha-hydroxyestrone on bone, uterus and mammary gland in ovariectomized growing rats.
Lotinun S; Westerlind KC; Turner RT
J Endocrinol; 2001 Jul; 170(1):165-74. PubMed ID: 11431149
[TBL] [Abstract][Full Text] [Related]
9. Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female ACI rats induced by estrogen.
Weroha SJ; Lingle WL; Hong Y; Li SA; Li JJ
Horm Cancer; 2010 Feb; 1(1):34-43. PubMed ID: 21761349
[TBL] [Abstract][Full Text] [Related]
10. Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.
Mense SM; Singh B; Remotti F; Liu X; Bhat HK
Carcinogenesis; 2009 Jul; 30(7):1202-8. PubMed ID: 19406931
[TBL] [Abstract][Full Text] [Related]
11. Novel insight in estrogen homeostasis and bioactivity in the ACI rat model of estrogen-induced mammary gland carcinogenesis.
Pemp D; Esch HL; Hauptstein R; Möller FJ; Zierau O; Bosland MC; Geppert LN; Kleider C; Schlereth K; Vollmer G; Lehmann L
Arch Toxicol; 2019 Jul; 93(7):1979-1992. PubMed ID: 31119341
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic analysis uncovered an association of serum phospholipid levels with estrogen-induced mammary tumors in female ACI/Seg rats.
Okamoto Y; Aoki A; Ueda K; Jinno H
Toxicol Lett; 2018 May; 288():65-70. PubMed ID: 29454887
[TBL] [Abstract][Full Text] [Related]
13. The O-methylation of 4-hydroxyestradiol is inhibited by 2-hydroxyestradiol: implications for estrogen-induced carcinogenesis.
Roy D; Weisz J; Liehr JG
Carcinogenesis; 1990 Mar; 11(3):459-62. PubMed ID: 2311190
[TBL] [Abstract][Full Text] [Related]
14. Response of serum prolactin to catechol estrogen in the immature rat.
Barbieri RL; Todd RB; Morishita H; Ryan KJ; Fishman J; Naftolin F
Fertil Steril; 1980 Oct; 34(4):391-3. PubMed ID: 6252068
[TBL] [Abstract][Full Text] [Related]
15. Less Carcinogenic Chlorinated Estrogens Applicable to Hormone Replacement Therapy.
Okamoto Y; Jinno H; Itoh S; Shibutani S
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281275
[TBL] [Abstract][Full Text] [Related]
16. Lack of Cell Proliferative and Tumorigenic Effects of 4-Hydroxyestradiol in the Anterior Pituitary of Rats: Role of Ultrarapid O-Methylation Catalyzed by Pituitary Membrane-Bound Catechol-O-Methyltransferase.
Wang P; Mills LH; Song JH; Yu J; Zhu BT
Chem Res Toxicol; 2017 Jul; 30(7):1448-1462. PubMed ID: 28616971
[TBL] [Abstract][Full Text] [Related]
17. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens.
Newbold RR; Liehr JG
Cancer Res; 2000 Jan; 60(2):235-7. PubMed ID: 10667565
[TBL] [Abstract][Full Text] [Related]
18. Carcinogenic potential of fluorinated estrogens in mammary tumorigenesis.
Okamoto Y; Jinno H; Itoh S; Shibutani S
Toxicol Lett; 2020 Jan; 318():99-103. PubMed ID: 31669098
[TBL] [Abstract][Full Text] [Related]
19. Association between urinary levels of bisphenol-A and estrogen metabolism in Korean adults.
Kim EJ; Lee D; Chung BC; Pyo H; Lee J
Sci Total Environ; 2014 Feb; 470-471():1401-7. PubMed ID: 23954212
[TBL] [Abstract][Full Text] [Related]
20. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
